AtheroGenics Inc. (AGIX-NASDAQ) is the latest biotech implosion this morning. It went from bad to worse as its late-stage clinical study for heart disease treatment failed to meet endpoints, although the company is proceeding…
On Friday’s MAD MONEY on CNBC, Jim Cramer discussed Nastech Pharma (NSTK). This is one of the biotech zombies that has fallen from grace, but Cramer thinks they have some winning compounds worth a…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Morgan Stanley analyst Steven Harr has been warning Genentech and other drug firms that the record prices asked for new cancer drug treatments could create a backlash,…
Hollis Eden (HEPH), a micro-cap drug development company, is up roughly 7% at $2.68 pre-market after the company announced it was officially shelving its Neumune radiation treatment development because of the government’s withdrawal of…
Biotechnology MICROMET INC +16.00% NEOSE TECH INC +13.14% TRUBION PHARMACEUTIC +8.91% CYPRESS BIOSCIENCE +8.80% OBAGI MEDICAL +8.02% Diagnostic Substances TORREYPINES THERAPEU +12.83% GENE LOGIC INC +8.72% REMOTEMDX INC +6.96% RG GLBL LIFESTYLS +6.40% SYNOVICS…
Amgen is definitely seeing hard times lately, as they have been a fixture of the 52-week low club for a couple of weeks now. For those who don’t regularly follow the stock, the company…
by H.S. AyoubBioHealth Investor.com Biotechnology CRITICAL THERAPEUTIC +21.70% LEV PHARMACEUTICALS +14.72% MOLECULAR INS PHARMA +11.40% IDERA PHARMACEUTICAL +6.71% FERMAVIR PHARMACEUTL +6.25% Diagnostic Substances AMER BIO MEDICA +12.04% INTERLEUKIN GENETICS +8.29% COLEY PHARMACEUTICAL +2.89% GENE…
by H.S. AyoubBioHealth Investor.com Shares of Thermogenesis (KOOL) jumped both in price and volume during the last hour of trading on Wednesday. The stock ended regular hours trading at $3.13, up more than 16%,…
From BioHealth Investor Biotechnology POLYDEX PHARM LTD +28.84% CERAGENIX PHARMACUTL +9.00% PANACOS PHARMA INC +7.76% PIPEX PHARMACEUTICAL +4.62% MICROMET INC +4.59% Diagnostic Substances RG GLBL LIFESTYLS +8.00% HEALTHCARE TECH LTD +4.32% INTERLEUKIN GENETICS +2.53%…
Amgen (AMGN) got called in on the carpet for not make clear that a couple of its drugs had big time side effect. According to The Associated Press: "the FDA added warnings to the…
Boston Scientific (BSX) is considering spinning off part of its endosurgery division to the public.One analyst was quoted by The Wall Street Journal as saying: "People may take this as further evidence that they’re…
From BioHealth Investor Biotechnology LA JOLLA PHARMA +30.29% AURIGA LABORATORIES +23.33% ANTIGENICS INC +12.50% MEDIVATION INC +6.83% DYADIC INTERNATIONAL +6.78% Diagnostic Substances GENE LOGIC INC +13.13% ORCHID CELLMARK INC +9.34% PRESSURE BIOSCIENC +4.90% ROSETTA…
On CNBC’s MAD MONEY, Cramer said he is unveiling a medical delivery technology company and will be doing this as part of a new series. He is reviewing Hansen Medical (HNSN-NASDAQ), but you have…
This morning HealthShares(TM) ETF’s, from XShares Advisors LLC, is launching 9 new ETF’s dedicated to various aspects of healthcare. This is in addtion to the 5 launched in January, so there are now 14…
by H.S. AyoubBioHealth Investor.com There have been many debates over the last couple of years as to the varying degree of blood clotting events associated with the use of drug-eluted cardiac stents. In the…